Immuron IMRN
NASDAQ IMRN
$0.97 -0.05 (-4.90%)
At close: Oct 21, 2026 · 4:00 PM EDT

Immuron (IMRN) Income from Continuing Operations (2023 - 2024)

Updated

Immuron (IMRN) recorded Income from Continuing Operations of -$3.84 million in FY2026 (year ended Aug 28, 2026).

Analysis

Immuron (IMRN) Income from Continuing Operations (2023 - 2024) Analysis & Trends

Starting with FY2015, Immuron's Income from Continuing Operations history includes 12 fiscal years.

  • Annual Income from Continuing Operations has ranged from -$5.22 million in FY2025 to -$69,370 in FY2024 over the past five years.
  • Per Business Quant data, IMRN's Income from Continuing Operations was -$5.22 million in FY2025, -$69,370 in FY2024, -$2.07 million in FY2023 and -$1.88 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 5.53 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 3.62 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.51 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -10.50 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -246.00 Mn
10 Immuron 7.32 Mn -9.83 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -4.54 Mn
Sep 9, 2024 -46,223.37
Dec 31, 2023 -24,649.80
API Access

Immuron Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=IMRN&period=max&api_key=YOUR_API_KEY